Complete Phenotypic Recovery of an Alzheimer's Disease Model by a Quinone-Tryptophan Hybrid Aggregation Inhibitor

Roni Scherzer-Attali, Riccardo Pellarin, Marino Convertino et al. · 2010

Read Complete Phenotypic Recovery of an Alzheimer's Disease Model by a Quinone-Tryptophan Hybrid Aggregation Inhibitor by Roni Scherzer-Attali, Riccardo Pellarin, Marino Convertino et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0011101.txt.

Description

Scherzer-Attali, Pellarin, Convertino and colleagues reported Alzheimer research in PLOS ONE in 2010. They tested a hybrid drug built from a quinone and an amino acid in a mouse model of the disease. The drug was designed to stop harmful proteins from clumping in the brain.

In the mouse model, treatment led to a full recovery of disease traits, a striking result for this field. Protein clumps are a core feature of Alzheimer disease, so blocking them strikes at a root process. The team presents the hybrid as a strong lead for drug hunting. More work is needed before any human use can be judged.

Catalog record

CREATORRoni Scherzer-Attali, Riccardo Pellarin, Marino Convertino et al.
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE69 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0011101

Browse the full library · About the Tower of Babel